Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Dividends Paid - Common came in at $3.2 billion in Q2 2026, up 3.13% year-over-year from $3.1 billion in Q2 2025, and up 3.07% quarter-over-quarter from $3.1 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $3.2 billion for Q2 2026.
- In Q2 2026, Dividends Paid - Common rose 3.13% year-over-year to $3.2 billion; the TTM figure through Jun 2026 stood at $12.6 billion (up 4.42% YoY), while the FY2025 annual figure was $12.4 billion, up 4.72% from the prior year.
- Dividends Paid - Common came in at $3.2 billion for Q2 2026 at Johnson & Johnson, up from $3.1 billion in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $3.4 billion in Q1 2023 to a low of $2.8 billion in Q2 2022.
- Average Dividends Paid - Common over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2024.
- The largest YoY upside for Dividends Paid - Common was 5.56% in 2023 against a maximum downside of 16.74% in 2023.
- Over 5 years, Dividends Paid - Common stood at $2.8 billion in 2022, then advanced by 2.8% to $2.9 billion in 2023, then gained by 4.15% to $3.0 billion in 2024, then rose by 4.93% to $3.1 billion in 2025, then rose by 3.07% to $3.2 billion in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $3.2 billion in Q2 2026, $3.1 billion in Q1 2026, and $3.1 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.87 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.45 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 1.29 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 6.09 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 3.23 Bn |
| Mar 29, 2026 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Mar 31, 2024 | 2.87 Bn |
| Dec 31, 2023 | 2.87 Bn |
| Oct 1, 2023 | 2.87 Bn |
| Jul 2, 2023 | 3.09 Bn |
| Apr 2, 2023 | 2.94 Bn |
| Jan 1, 2023 | 3.44 Bn |
| Apr 3, 2022 | 2.79 Bn |
| Oct 3, 2021 | 2.79 Bn |
| Jul 4, 2021 | 2.79 Bn |
| Apr 4, 2021 | 2.66 Bn |
| Jan 3, 2021 | 2.66 Bn |